Paid Clinical Trials in Mount Kisco, NY
As of August 2026, 42 paid clinical trials are recruiting in Mount Kisco, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mount Kisco offers studies at sites including Northern Westchester Hospital for conditions such as Major Depressive Disorder, Anatomic Stage II Breast Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mount Kisco
Trials by drug in Mount Kisco
Filter results
39 clinical trials
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Molecular Genetics Studies of Cancer Patients and Their Relatives
Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Product Surveillance Registry
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Top Research Study Locations in Mount Kisco
Researchers run research studies in Mount Kisco, NY at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northern Westchester Hospital | Anatomic Stage II Breast Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 19 |
| Bioscience Research LLC | Depressive Disorder, Major | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Bioscience Research | Migraine | 1 |
| Bioscience Research Llc. | Major Depressive Disorder | 1 |
| Bioscience Research, LLC | Major Depressive Disorder | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Galderma Investigational | Prurigo Nodularis | 1 |
| Galderma Investigational Site - 8282 | Atopic Dermatitis | 1 |
| Mount Kisco Medical Group at Northern Westchester Hospital | Malignant Neoplasm | 1 |
| Northern Westchester Cancer Center | Pancreatic Ductal Adenocarcinoma | 1 |
| Northwell Health Northern Westchester Hospital | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| Northwell Health- Northern Westchester Hospital | Breast Cancer | 1 |
| Optum Medical Care, PC | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Differentiated Thyroid Cancer | 1 |
| The Center for Dermatology Cosmetics & Laser Surgery | Acne Scars | 1 |
| The Center for Dermatology, Cosmetic & Laser Surgery | Moderate to Severe Glabellar Lines | 1 |
| Vanda Investigative Site | Hypertension, Uncontrolled Hypertension | 1 |
Active & Upcoming Studies in Mount Kisco (2026)
Recruiting trials in Mount Kisco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (3 active studies)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis · Phase 3 · Duke University
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension · Phase 2 · Vanda Pharmaceuticals
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
Common conditions studied in Mount Kisco
- Major Depressive Disorder (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Advanced Esophageal Adenocarcinoma (2 active studies)
- Advanced Gastric Adenocarcinoma (2 active studies)
- Advanced Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Binge-Eating Disorder (2 active studies)
Leading research sponsors in Mount Kisco
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Axsome Therapeutics, Inc.
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Mount Kisco?
There are approximately 42 recruiting clinical trials in Mount Kisco, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mount Kisco pay participants?
Most recruiting trials in Mount Kisco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mount Kisco?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mount Kisco?
The most common conditions under active study in Mount Kisco include Major Depressive Disorder (5), Anatomic Stage II Breast Cancer AJCC v8 (3), Advanced Esophageal Adenocarcinoma (2), Advanced Gastric Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mount Kisco?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mount Kisco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mount Kisco?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mount Kisco?
Recruiting research sites in Mount Kisco include Northern Westchester Hospital, Bioscience Research LLC, Neurocrine Clinical Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mount Kisco right now?
The largest active categories in Mount Kisco are Cancer & tumors (17), Cardiovascular (3), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.